This research validated a genetic test that uses a 40-gene profile to predict which melanoma patients have a higher risk of metastasis. This tool helps dermatologists and oncologists identify patients who may benefit from more aggressive treatment and closer monitoring.
Wysong A, et al. "Validation of a 40-gene expression profile test to predict metastatic risk in localized melanoma." Journal of the American Academy of Dermatology. 2021.
